The effect of osteoprotegerin on implant osseointegration in ovariectomized rats

INTRODUCTION: Osteoprotegerin (OPG), the endogenous inhibitor of RANKL, prevents or reverses bone loss in a variety of preclinical models of bone disease. Preclinical studies indicate that osteoporosis significantly impairs implant fixation. This study aims to investigate the role of OPG in implant...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yiming, Hu, Jing, Liu, Biao, Jiang, Xiliang, Li, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Experimental Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332467/
https://www.ncbi.nlm.nih.gov/pubmed/28261305
http://dx.doi.org/10.5114/aoms.2017.65468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332467/
https://www.ncbi.nlm.nih.gov/pubmed/28261305
http://dx.doi.org/10.5114/aoms.2017.65468

Ejemplares similares